Government of Greece Report issue

Government Phase 2 Phase 3 Phase 4

Organization Overview

First Clinical Trial
2013
NCT02409537
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

251 Hellenic Air Force & VA General Hospital | 251 Hellenic Air Force & VA Hospital | 424 General Military Hospital | Aeromedical Center, Thessaloniki | Greek Ministry of Development | Greek Secretariat for Research and Technology

Active Ingredients

Drugs in Phase 4 Trials (2)

alendronic acid (fosamax) (1 trial)

denosumab (prolia) (1 trial)

Drugs in Phase 3 Trials (1)

nitroglycerin (transderm-nitro) (1 trial)

Drugs in Phase 2 Trials (1)

red wine (1 trial)

Drugs in Other Trials (3)

egg (1 trial)

maltodextrin (1 trial)

whey protein (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hypercholesterolemia (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 7